| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $180K | — | +40.1% |
| Cost of Revenue | $66K | — | — |
| Gross Profit | $115K | — | -10.9% |
| R&D Expense | $406K | — | +16.2% |
| SG&A Expense | $1.9M | — | +302.6% |
| Operating Income | -$2.4M | — | -156.7% |
| Net Income | -$3.3M | — | -246.6% |
| EPS (Basic) | -$0.09 | — | -200.0% |
| EPS (Diluted) | -$0.09 | — | -200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $50K | +123.0% | +15.2% |
| Current Assets | $244K | +99.7% | +35.9% |
| Total Assets | $245K | +98.1% | +36.8% |
| Current Liabilities | $6.3M | +107.6% | +69.2% |
| Total Liabilities | $6.3M | +42.6% | +69.2% |
| Stockholders' Equity | -$6.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$32K | — | +94.7% |
| Financing Cash Flow | $88K | — | -80.2% |
| -70.9% |